39 related articles for article (PubMed ID: 1433916)
1. [Clinicopathological study of 6 cases of mantle zone lymphoma].
Shibuya A; Muraki Y; Satoh Y; Kobayashi T; Kojima H; Nagasawa T; Abe T; Tomiyama J; Kudoh H; Adachi Y
Rinsho Ketsueki; 1992 Jun; 33(6):770-5. PubMed ID: 1433916
[TBL] [Abstract][Full Text] [Related]
2. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
3. Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.
O'Connor OA; Wright J; Moskowitz C; Muzzy J; MacGregor-Cortelli B; Stubblefield M; Straus D; Portlock C; Hamlin P; Choi E; Dumetrescu O; Esseltine D; Trehu E; Adams J; Schenkein D; Zelenetz AD
J Clin Oncol; 2005 Feb; 23(4):676-84. PubMed ID: 15613699
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
5. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological studies on bone marrow involvement of non-Hodgkin's lymphoma].
Chen H; Qian L; Shen J
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):513-5. PubMed ID: 11235578
[TBL] [Abstract][Full Text] [Related]
7. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
8. [Experience with results of treatment of non-Hodgkin's lymphoma].
Gurzó M; Dobos K; Bérczi M; Varga G; Kelényi G
Orv Hetil; 1992 May; 133(18):1091-7. PubMed ID: 1579348
[TBL] [Abstract][Full Text] [Related]
9. Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.
Rummel MJ; Al-Batran SE; Kim SZ; Welslau M; Hecker R; Kofahl-Krause D; Josten KM; Dürk H; Rost A; Neise M; von Grünhagen U; Chow KU; Hansmann ML; Hoelzer D; Mitrou PS
J Clin Oncol; 2005 May; 23(15):3383-9. PubMed ID: 15908650
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma--a clinicopathological study of 13 cases.
Basu D; Yaranal PJ; Kalyan K; Soundararaghavan J
Malays J Pathol; 2005 Jun; 27(1):17-22. PubMed ID: 16676688
[TBL] [Abstract][Full Text] [Related]
11. Mantle zone lymphoma. Immuno- and enzymehistochemical studies on the cell of origin.
van den Oord JJ; de Wolf-Peeters C; Pulford KA; Mason DY; Desmet VJ
Am J Surg Pathol; 1986 Nov; 10(11):780-8. PubMed ID: 2946246
[TBL] [Abstract][Full Text] [Related]
12. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
13. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow involvement in non-Hodgkin's lymphoma in Zimbabwe.
Adewuyi B; Coutts A; Levy L; Klein S; Muronda C
East Afr Med J; 1994 Dec; 71(12):773-5. PubMed ID: 7705245
[TBL] [Abstract][Full Text] [Related]
15. Stage IE non-Hodgkin's lymphoma involving the dura: A clinicopathologic study of five cases.
Miranda RN; Glantz LK; Myint MA; Levy N; Jackson CL; Rhodes CH; Glantz MJ; Medeiros LJ
Arch Pathol Lab Med; 1996 Mar; 120(3):254-60. PubMed ID: 8629900
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of mantle zone lymphoma.
Mori N; Oka K; Kojima M
Am J Clin Pathol; 1988 Aug; 90(2):143-8. PubMed ID: 3293418
[TBL] [Abstract][Full Text] [Related]
18. Mantle zone lymphoma. A clinicopathologic study of 22 cases.
Duggan MJ; Weisenburger DD; Ye YL; Bast MA; Pierson JL; Linder J; Armitage JO
Cancer; 1990 Aug; 66(3):522-9. PubMed ID: 2364363
[TBL] [Abstract][Full Text] [Related]
19. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma.
Weisenburger DD; Kim H; Rappaport H
Cancer; 1982 Apr; 49(7):1429-38. PubMed ID: 6895860
[TBL] [Abstract][Full Text] [Related]
20. A case report of mantle zone lymphoma progressing into follicular lymphoma.
Oka K; Mori N; Kojima M; Miyamoto T
Am J Clin Pathol; 1986 Aug; 86(2):220-4. PubMed ID: 3526862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
